Mayo Clinic Laboratories’ BioPharma Diagnostics team collaborates with biopharmaceutical, diagnostic, and other biotechnology companies to offer a wide range of laboratory testing and biopharma support for all phases of clinical trials.

The following example demonstrates how BioPharma Diagnostics collaborated with a diagnostics company to meet their clinical and research testing needs. Identifying information has been removed.

Opportunity

An international diagnostics company is completing an observational study of patients with liver cirrhosis with the goal of validating a specific serum metabolite constellation to detect early hepatocellular carcinoma (HCC) lesions in liver cirrhosis. The study population includes patients with liver cirrhosis scheduled for surveillance for HCC using abdominal ultrasound and blood-based liver function tests, which may include testing for biomarkers. Enrolled patients will have specimens and data collected at multiple touchpoints, including a baseline and up to four follow-up visits.

Collaboration